The IARC uses a rigorous evaluation process involving scientific experts to classify agents based on their carcinogenic risk. The classification ranges from Group 1 (carcinogenic to humans) to Group 4 (probably not carcinogenic to humans). The evaluation considers the strength of evidence from human and animal studies, as well as mechanistic data.
